Two Colorado studies find resistance mechanisms in ALK+ and ROS1+ cancers
Credit: University of Colorado Cancer Center Targeted treatments have revolutionized care for lung cancer patients whose tumors harbor ALK or ROS1 alterations. Basically, cancers may...








